Cardlytics, Inc. Common Stock (CDLX)
Cardlytics, Inc. is a technology-focused marketing platform that specializes in purchase intelligence and rewards. Founded in 2008, it provides banks and financial institutions with targeted advertising solutions based on consumer purchase data, helping brands reach relevant audiences through personalized offers and promotions. The company's platform leverages transaction data to optimize marketing strategies and improve customer engagement.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 19, 2008 | $0.25 | 2008-08-05 | 2008-08-05 |
| May 15, 2008 | $0.50 | 2008-04-29 | 2008-05-01 |
| February 14, 2008 | $0.25 | 2008-02-06 | 2008-01-31 |
| November 19, 2007 | $0.25 | 2007-11-13 | 2007-11-05 |
| August 15, 2007 | $0.25 | 2007-07-30 | 2007-08-01 |
Dividends Summary
- Cardlytics, Inc. Common Stock has issued 19 dividend payments over the past 4 years
- The most recent dividend was paid 6241 days ago, on August 19, 2008
- The highest dividend payed out to investors during this period was $1 per share
- The average dividend paid during this period was $0.35 per share.
Company News
Cardlytics reported mixed Q2 2025 results with declining revenue but improved earnings, highlighting challenges in monetizing its growing user base while expanding partnerships beyond traditional banking channels.
Cardlytics, Inc. is facing a federal securities class action lawsuit due to alleged false and/or misleading statements about its financial performance and business prospects.
Cardlytics (NASDAQ:CDLX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 4 0 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $14.86, a high estimate of $18.00, and a low estimate of $12.00. Observing a 7.22% increase, the current average has risen from the previous average price target of $13.86. Understanding Analyst Ratings: A Comprehensive Breakdown The perception of Cardlytics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Kyle Peterson Needham Maintains Buy $12.00 $12.00 Jason Kreyer Craig-Hallum Lowers Buy $12.00 $18.00 Kyle Peterson Needham Lowers Buy $12.00 $17.00 Kyle Peterson Needham Raises Buy $17.00 $15.00 Jacob Stephan Lake Street Raises Buy $18.00 $13.00 Jason Kreyer Craig-Hallum Raises Buy $18.00 $10.00 Kyle Peterson Needham Raises Buy $15.00 $12.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cardlytics. This information offers a snapshot of how analysts perceive the current state of the company. Rating: Offering a ...Full story available on Benzinga.com
Cardlytics (CDLX) delivered earnings and revenue surprises of 44.19% and 10.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Cardlytics shares surged to their best day on record Tuesday after the digital-advertising company boosted its quarterly forecast.